Could serum S100B be a predictor of neuronal damage and clinical poor outcomes associated with the use of synthetic cannabinoids? S100B to predict neuronal damage of SC in the ED

YILMAZ, SERKAN; Karakayali, Onur; Kale, Ebru; Akdogan, Ahmet

doi:10.1016/j.ajem.2017.08.053

Could serum S100B be a predictor of neuronal damage and clinical poor outcomes associated with the use of synthetic cannabinoids? S100B to predict neuronal damage of SC in the ED

Atıf İçin Kopyala

YILMAZ S., Karakayali O., Kale E., Akdogan A.

AMERICAN JOURNAL OF EMERGENCY MEDICINE, cilt.36, sa.3, ss.435-441, 2018 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 36 Sayı: 3
Basım Tarihi: 2018
Doi Numarası: 10.1016/j.ajem.2017.08.053
Dergi Adı: AMERICAN JOURNAL OF EMERGENCY MEDICINE
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.435-441
Kocaeli Üniversitesi Adresli: Evet

Özet

Aim: This study aims to evaluate the serum S100B levels to predict neuronal damage and poor clinical outcomes associated with the use of synthetic cannabinoids.